Related Experiment Video
Updated: May 15, 2026
07:43
Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons
Published on: January 7, 2019
Pierre Ménétrier and his disease.
Robert J Coffey1, Jarred Tanksley
1MRBIV, 2213 Garland Ave, Nashville, TN 37232-0441, USA. robert.coffey@vanderbilt.edu
Transactions of the American Clinical and Climatological Association
|January 11, 2013
Summary
Ménétrier's disease, a rare disorder, is characterized by increased transforming growth factor-alpha (TGFα) and epidermal growth factor receptor (EGFR) activity. Our research reviews the historical context and recent findings on this condition.
Area of Science:
- Gastroenterology
- Pathophysiology
- Rare Diseases
Background:
- Ménétrier's disease, first described in 1888, is a rare gastric disorder characterized by enlarged rugal folds.
- Key clinical and pathological features described by Ménétrier remain relevant today.
Discussion:
- Our laboratory's 20-year research program has focused on the molecular mechanisms underlying Ménétrier's disease.
- We have identified increased transforming growth factor-alpha (TGFα) expression as a critical factor.
- Heightened epidermal growth factor receptor (EGFR) activity is also implicated in the disease's pathogenesis.
Key Insights:
- TGFα and EGFR signaling pathways play a significant role in the development of Ménétrier's disease.
- Understanding these molecular pathways offers potential therapeutic targets.
Outlook:
- Further research is needed to fully elucidate the complex pathogenesis of Ménétrier's disease.
- Future studies should explore novel therapeutic strategies targeting TGFα and EGFR.
- Continued investigation into rare gastrointestinal disorders like Ménétrier's disease is crucial for advancing patient care.
Related Concept Videos
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:22Lysosomal Hydrolases
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
01:30Peripheral Artery Disease I: Introduction
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...